Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
XBiotech Inc. is a biopharmaceutical company specializing in discovering and developing True Human monoclonal antibodies from naturally immune donors. Its focus includes therapies targeting inflammatory and infectious diseases, notably IL-1a inhibitors for conditions like cancer, arthritis, and stroke. The company leverages proprietary manufacturing and clinical infrastructure, aiming to deliver safer, more effective biologics with potential for targeted, differentiated treatments across multiple medical indications.
This description was generated via AI from an annual report. Updated about 1 year ago.